Immunohematology Market in Europe is projected to expand at a significant CAGR to 2025 | TMR Study

2022-10-25
PRNewswire
合作抗体
Demand for safe and quality blood- and plasma-derived products especially in blood banks propelling strides in immunohematology market; automation in devices present value-grab opportunity for firms to tap into massive demand in hospitals
Growing burden of transfusion-related diseases generating substantial revenue streams to market players; massive uptake of products in North America to steer revenues
WILMINGTON, Del., Oct. 26, 2022 /PRNewswire/ -- Based on a detailed scrutiny of recent immunohematology market trends, a study by TMR analysts found that emphasis on the safety of blood products in transfusion medicine is a major underpinning factor. Collating all pertinent immunohematology market data followed by meticulous statistical analysis allowed them to conclude that advancements in treatments of hematological diseases favorably influenced the growth dynamics.
The study has projected the immunohematology market to advance at CAGR of 3.5% during the forecast period of 2017 to 2025. A detailed market analysis of immunohematology market dynamics by the authors of the report found that demand in hospitals is driving massive revenue growth for players. They have projected the segment to be the leading end-user segment in the global immunohematology market during the forecast period.
Get Exclusive PDF Sample Copy of
– https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31544
Key Findings of Immunohematology Market Study
Product Automation Opens up New Vistas of Growth: The study authors observed that automation is a major technological advancement in immunohematology market and will continue to generate substantial lucrative avenues for firms. Need for new techniques and technologies for ensuring quality and safety of blood products have extended the horizon. Advantages such as objectivity and reproducibility of tests and low turnaround time are fueling the adoption of automated products in immunohematology market. A bulk of demand for automated equipment comes from hospitals, the study found.
Growing Burden of Transfusion-Related Diseases and Prevalence of Hematological Disorders to Steer Demand: Rise in burden of transfusion-related diseases is a key factor that is being capitalizing on by players in immunohematology market. Over the years, expansion of blood banks in several parts of the world and global growing incidence of hematological disorders are spurring the demand for automated equipment for immunohematology tests. Furthermore, advances in transfusion medicine have led to the demand for high quality plasma products in the patient population. This has positively impacted the immunohematology market size
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=31544
Immunohematology Market: Key Drivers
Worldwide rise in incidence of many hematologic disorders is a key driver of the immunohematology market. Of note, the prevalence of leukemia is high, causing a glaring health burden, which has underpinned technological advancements in its diagnosis and treatments.
Strides in immunohematology market are also propelled by growing number of blood banks, increasingly supported by public funding in healthcare.
Immunohematology Market: Regional Growth Dynamics
North America is projected to hold a major share of the global immunohematology market during the forecast period of 2017 – 2025. Rise in number of blood transfusions in the region has spurred the revenue growth. Additionally, continuous advancements made in blood- and plasma-derived products and enormous progress being made in transfusion service will reinforce the prospects of the regional market.
Europe is another region in immunohematology market that has emerged as potentially lucrative in 2017. In recent years, the revenue generation has been fueled by high product adoption and rise in demand for blood products.
Immunohematology Market: Competition Landscape
The study found that most players are leveraging both inorganic and organic strategies in a bid to gain shares in immunohematology market. Some key players are also constantly expanding their portfolio in blood-typing products to gain a competitive edge over their rivals and peers.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=31544
Immunohematology Market Segmentation
Product
Semi-automatic/Non-automatic
Immunohematology Reagents
Application
Antibody Screening
End-user
Hospitals
500+ Beds
200–499 Beds
Less Than 200 Beds
Academic & Research Institutes
Blood Banks
Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Australia & New Zealand
Japan
China
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Israel
Rest of Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Mice Model Generation Market: The global mice model generation market is anticipated to reach more than US$ 918.4 Mn by 2031 at a CAGR of 8.1% from 2022 to 2031.
Cancer Biomarkers Market: The global cancer biomarkers market is anticipated to reach more than US$ 31.4 Bn by 2031 at a CAGR of 9.9% from 2022 to 2031.
Analytical Standards Market: The global analytical standards market is anticipated to reach more than US$ 2.29 Bn by the end of 2031 at a CAGR of 6.7% from 2022 to 2031.
Mice Model Technologies Market: The global mice model technologies market is anticipated to reach US$ 3.2 Bn by 2031 at a CAGR of 7.4% from 2022 to 2031.
Soft Tissue Allografts Market: The global soft tissue allografts market is anticipated to reach more than US$ 6.3 Bn by the end of 2031 at a CAGR of 5.5% from 2022 to 2031.
Animal Genetics Market: The global animal genetics market is anticipated to reach more than US$ 9.1 Bn by the end of 2031 at a CAGR of 6.7% from 2022 to 2031.
Transplant Drug Monitoring Assay Market: The global transplant drug monitoring assay market is anticipated to reach more than US$ 542 Mn by the end of 2031 at a CAGR of 11.0% from 2022 to 2031.
PRP and PRF in Cosmetics Market: The global PRP and PRF in cosmetics market is anticipated to exceed US$ 483 Mn by 2031 at a CAGR of 12.6% from 2022 to 2031.
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyse information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact:
Rohit Bhisey
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
SOURCE Transparency Market Research
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
适应症
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。